Why the study?
Does a higher cardio-ankle vascular index (CAVI) correlate with advanced coronary artery calcification and significant coronary stenosis in asymptomatic individuals?
Does a higher cardio-ankle vascular index (CAVI) correlate with advanced coronary artery calcification and significant coronary stenosis in asymptomatic individuals?
In asymptomatic individuals, a cardio-ankle vascular index (CAVI) ≥8 is independently associated with advanced coronary artery calcification and significant coronary stenosis, suggesting its potential utility as a non-invasive screening tool for subclinical atherosclerosis.
Should not yet change asymptomatic screening; supports CAVI as a correlate of coronary burden but requires prospective validation.
AIM: The cardio-ankle vascular index (CAVI) is an index of arterial stiffness. We investigated the association of CAVI with the severity of coronary artery calcification (CAC) and coronary stenosis by coronary computed tomography angiography (CTA) in an asymptomatic population. METHODS: A total of 549 asymptomatic Korean individuals who underwent CAVI and CTA were analyzed retrospectively. CAC and coronary stenosis were measured by CTA and assessed for the correlation with CAVI. RESULTS: The degree of CAC and coronary stenosis demonstrated a significant correlation with CAVI (r= 0.187, p<0.001 and r= 0.212, p<0.001 for the CAC score and stenosis, respectively). After adjustment for potential confounders, including age, gender, hypertension, diabetes mellitus, and dyslipidemia, a predefined cutoff value of CAVI ≥8 was associated with advanced CAC (CAC ≥300) and significant coronary stenosis (stenosis ≥50%). Specifically, the adjusted odds ratio (95% confidence interval) of CAC ≥300 and coronary stenosis ≥50% was 3.57 (1.92-6.66) and 2.81 (1.13-7.00), respectively. Additional inclusion of CAVI improved the predictive power of the receiver operating characteristic curves for predicting coronary atherosclerosis based on traditional risk factors; the area under the curve for predicting CAC ≥300 and coronary stenosis ≥50% increased from 0.739 to 0.791 (p for difference= 0.023), and from 0.761 to 0.842 (p= 0.032), respectively. CONCLUSIONS: CAVI reflects coronary atherosclerosis and may be used as a screening tool for assessing subclinical atherosclerotic burden in an asymptomatic population.
No takes yet. Share an insight, caveat, or question.
Park et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: